Streetbeat News

Regulatory

ATXS

Astria Therapeutics, Inc. (NASDAQ:ATXS) has announced the publication of preclinical data for STAR-0215, a potential long-acting therapy for hereditary angioedema (HAE), in the Journal of Pharmacology and Experimental Therapeutics. The data supports STAR-0215's profile as a potent plasma kallikrein inhibitor with a long half-life. Initial results from a Phase 1a trial support STAR-0215's target profile, with final results expected in Q4 2023. The Phase 1b/2 ALPHA-STAR trial is ongoing, with initial results expected in mid-2024.

Portfolio Pulse from Happy Mohamed

August 31, 2023 | 12:10 pm

AMD

BABA

FXI

KWEB

NVDA

Alibaba's stock is trading lower, in line with broader indexes iShares China Large-Cap ETF and KraneShares Trust KraneShares CSI China Internet ETF. This is due to China's manufacturing activity contracting for a fifth straight month, putting pressure on the government to support economic growth. The US government has also broadened its crackdown on the exports of AI chips developed by Nvidia Corp and Advanced Micro Devices Inc to regions beyond China.

Portfolio Pulse from Anusuya Lahiri

August 31, 2023 | 12:10 pm

FXI

China's central bank is planning to adjust interest rates on mortgages, according to Reuters. This could potentially impact the real estate market and overall economy in China.

Portfolio Pulse from Benzinga Newsdesk

August 31, 2023 | 12:10 pm

NSPR

InspireMD, Inc. (NASDAQ:NSPR) has announced that an abstract detailing 30-day results from its C-Guardians U.S. IDE clinical trial has been accepted for presentation at the VIVA23 conference. The trial is evaluating the safety and efficacy of the CGuard™ Carotid Stent System for the treatment of carotid artery stenosis. The company anticipates primary endpoint results from the study in H2 2024.

Portfolio Pulse from Happy Mohamed

August 31, 2023 | 12:07 pm

AMD

AMZN

BABA

GOOG

INTC

NVDA

The US government has expanded its restrictions on exports of AI chips developed by Nvidia and Advanced Micro Devices to regions beyond China, including several Middle Eastern nations. However, Nvidia stated that these restrictions would not significantly disrupt its financial outcome. Both Nvidia and AMD have unveiled strategies to design and manufacture less potent AI chips for the Chinese market. Quanta Cloud Technology, a key ally of Nvidia, expects to double its AI server sales by 2024 due to increasing global AI integration.

Portfolio Pulse from Anusuya Lahiri

August 31, 2023 | 12:05 pm

AZN

ENHERTU, a drug developed by Daiichi Sankyo and AstraZeneca, has been granted two additional Breakthrough Therapy Designations (BTDs) in the U.S. for the treatment of adult patients with certain types of HER2 positive tumors. The drug has now received a total of seven BTDs. The FDA grants BTDs to accelerate the development and review of potential new medicines that address a significant unmet medical need.

Portfolio Pulse from Happy Mohamed

August 31, 2023 | 12:03 pm

COYA

Coya Therapeutics (NASDAQ:COYA) has published research on potential novel blood biomarkers in ALS patients that accurately reflect therapeutic responses when treated with Treg-enhancing therapies. The company plans to leverage these biomarkers in its upcoming clinical trial with COYA 302 in ALS patients. The biomarkers could serve as objective indicators of disease progression and clinical trial endpoint surrogates to therapies that enhance Treg function.

Portfolio Pulse from Happy Mohamed

August 31, 2023 | 12:01 pm

SILO

Silo Pharma has filed a PCT patent application for methods of treating Alzheimer's disease and ameliorating symptoms associated with Alzheimer's disease using Prucalopride and Ketamine.

Portfolio Pulse from Benzinga Newsdesk

August 31, 2023 | 11:48 am

EVTL

Vertical Aerospace has provided an update on the preliminary investigation into an incident that occurred on August 9. The company has not provided specific details about the incident or its potential impact on the company's operations.

Portfolio Pulse from Benzinga Newsdesk

August 31, 2023 | 11:44 am

SUP

Superior Industries International, Inc. (NYSE:SUP) announced that its subsidiary, Superior Industries Production Germany GmbH, has entered into Protective Shield Proceedings, a court-administered reorganization. The company has developed a revised operating plan to reduce costs, enhance revenues, and better address customer needs. Superior expects to recognize a non-cash charge of $82M in Q3 FY23 related to this strategic action but reaffirms its FY23 outlook.

Portfolio Pulse from Benzinga Newsdesk

August 31, 2023 | 11:40 am